VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q58639506 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010725.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q58639506‏
024 ‎‡a 0000-0003-0558-6541‏ ‎‡2 orcid‏
024 ‎‡a 25222091500‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q58639506‏
100 0 ‎‡a Ignacio Mahíllo-Fernández‏ ‎‡c researcher ORCID ID = 0000-0003-0558-6541‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Ignacio Mahíllo-Fernández‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A protective personal factor against disability and dependence in the elderly: an ordinal regression analysis with nine geographically-defined samples from Spain‏
670 ‎‡a Author's A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction‏
670 ‎‡a Author's Anxiety and depression predict musculoskeletal disorders in health care workers.‏
670 ‎‡a Author's Are article's social media mentions associated to citation counts? An analysis in highly influential medical journals.‏
670 ‎‡a Author's Asthma diagnosis using integrated analysis of eosinophil microRNAs‏
670 ‎‡a Author's Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish children‏
670 ‎‡a Author's Behavioral Evolution of Progressive Semantic Aphasia in Comparison with Nonfluent Aphasia‏
670 ‎‡a Author's Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction.‏
670 ‎‡a Author's Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.‏
670 ‎‡a Author's Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study)‏
670 ‎‡a Author's Circulating CXCL16 in Diabetic Kidney Disease.‏
670 ‎‡a Author's Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.‏
670 ‎‡a Author's Circulating miRNAs as diagnostic tool for discrimination of respiratory disease: Asthma, asthma-chronic obstructive pulmonary disease (COPD) overlap and COPD‏
670 ‎‡a Author's Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease‏
670 ‎‡a Author's Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease‏
670 ‎‡a Author's COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study‏
670 ‎‡a Author's COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer).‏
670 ‎‡a Author's Cost-effectiveness of different screening strategies‏
670 ‎‡a Author's Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.‏
670 ‎‡a Author's Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infa‏
670 ‎‡a Author's Diagnostic value of the stand-alone synthetic image in digital breast tomosynthesis examinations.‏
670 ‎‡a Author's Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.‏
670 ‎‡a Author's Do opinion articles attract more social attention than original research, relative to their citation counts?‏
670 ‎‡a Author's Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria.‏
670 ‎‡a Author's Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients‏
670 ‎‡a Author's Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib‏
670 ‎‡a Author's Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease‏
670 ‎‡a Author's Impact of Chiropractic Manipulation on Bone and Skeletal Muscle of Ovariectomized Rats.‏
670 ‎‡a Author's [Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]‏
670 ‎‡a Author's Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.‏
670 ‎‡a Author's Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study‏
670 ‎‡a Author's Incidence of nontraumatic spinal cord injury: a Spanish cohort study (1972-2008)‏
670 ‎‡a Author's Incidence of Traumatic Spinal Cord Injury in Aragón, Spain (1972–2008)‏
670 ‎‡a Author's Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa‏
670 ‎‡a Author's Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control‏
670 ‎‡a Author's Low Intracellular Water, Overhydration, and Mortality in Hemodialysis Patients‏
670 ‎‡a Author's Modifiable risk factors for increased arterial stiffness in outpatient nephrology‏
670 ‎‡a Author's N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease‏
670 ‎‡a Author's Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model‏
670 ‎‡a Author's Outcome of mild cognitive impairment comparing early memory profiles.‏
670 ‎‡a Author's Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.‏
670 ‎‡a Author's Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects.‏
670 ‎‡a Author's Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain‏
670 ‎‡a Author's Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008.‏
670 ‎‡a Author's Prevalence of disability in a composite ≥75 year-old population in Spain: a screening survey based on the International Classification of Functioning‏
670 ‎‡a Author's Prevalence of protein-energy wasting syndrome and its association with mortality in haemodialysis patients in a centre in Spain‏
670 ‎‡a Author's Sleep Disordered Breathing Is Highly Prevalent in Patients with Lung Cancer: Results of the Sleep Apnea in Lung Cancer Study‏
670 ‎‡a Author's Sonication of Abdominal Drains: Clinical Implications of Quantitative Cultures for the Diagnosis of Surgical Site Infection‏
670 ‎‡a Author's Spinal Cord Injury due to Tumour or Metastasis in Aragón, Northeastern Spain (1991-2008): Incidence, Time Trends, and Neurological Function.‏
670 ‎‡a Author's Suicide ideation among oncologic patients in a Spanish ward.‏
670 ‎‡a Author's Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies.‏
670 ‎‡a Author's Survival and mortality in older adults living at high altitude in Bolivia: a preliminary report‏
670 ‎‡a Author's Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.‏
670 ‎‡a Author's Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families.‏
670 ‎‡a Author's Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease‏
670 ‎‡a Author's Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study‏
670 ‎‡a Author's Weighing of risk factors for penetrating keratoplasty graft failure: application of Risk Score System.‏
909 ‎‡a (orcid) 0000000305586541‏ ‎‡9 1‏
909 ‎‡a (scopus) 25222091500‏ ‎‡9 1‏
919 ‎‡a costeffectivenessofdifferentscreeningstrategies‏ ‎‡A Cost-effectiveness of different screening strategies‏ ‎‡9 1‏
919 ‎‡a circulatingmirnasasdiagnostictoolfordiscriminationofrespiratorydiseaseasthmaasthmachronicobstructivepulmonarydiseasecopdoverlapandcopd‏ ‎‡A Circulating miRNAs as diagnostic tool for discrimination of respiratory disease: Asthma, asthma-chronic obstructive pulmonary disease (COPD) overlap and COPD‏ ‎‡9 1‏
919 ‎‡a coexistenceoflowvitamin500andhighfibroblastgrowthfactor23plasmalevelspredictsanadverseoutcomeinpatientswithcoronaryarterydisease‏ ‎‡A Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease‏ ‎‡9 1‏
919 ‎‡a comparisonof3predictiveclinicalriskscoresin603patientswithstablecoronaryarterydisease‏ ‎‡A Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease‏ ‎‡9 1‏
919 ‎‡a copdiscommonlyunderdiagnosedinpatientswithlungcancerresultsfromtherecoilstudy‏ ‎‡A COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study‏ ‎‡9 1‏
919 ‎‡a copdiscommonlyunderdiagnosedinpatientswithlungcancerresultsfromtherecoilstudyretrospectivestudyofcopdinfradiagnosisinlungcancer‏ ‎‡A COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer).‏ ‎‡9 1‏
919 ‎‡a circulatingfibroblastgrowthfactor23plasmalevelspredictadversecardiovascularoutcomesinpatientswithdiabetesmellituswithcoronaryarterydisease‏ ‎‡A Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.‏ ‎‡9 1‏
919 ‎‡a weighingofriskfactorsforpenetratingkeratoplastygraftfailureapplicationofriskscoresystem‏ ‎‡A Weighing of risk factors for penetrating keratoplasty graft failure: application of Risk Score System.‏ ‎‡9 1‏
919 ‎‡a usefulnessofboneturnovermarkersaspredictorsofmortalityriskdiseaseprogressionandskeletalrelatedeventsappearanceinpatientswithprostatecancerwithbonemetastasesfollowingtreatmentwithzoledronicacidtugamostudy‏ ‎‡A Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study‏ ‎‡9 1‏
919 ‎‡a usefulnessofacombinationofmonocytechemoattractantprotein1galectin3andnterminalprobrainnatriureticpeptidetopredictcardiovasculareventsinpatientswithcoronaryarterydisease‏ ‎‡A Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease‏ ‎‡9 1‏
919 ‎‡a unravellingthepathogenicroleandgenotypephenotypecorrelationoftheush2apcys759phevariantamongspanishfamilies‏ ‎‡A Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families.‏ ‎‡9 1‏
919 ‎‡a protectivepersonalfactoragainstdisabilityanddependenceintheelderlyanordinalregressionanalysiswith9geographicallydefinedsamplesfromspain‏ ‎‡A A protective personal factor against disability and dependence in the elderly: an ordinal regression analysis with nine geographically-defined samples from Spain‏ ‎‡9 1‏
919 ‎‡a unravellingthepathogenicroleandgenotypephenotypecorrelationoftheush2ap‏ ‎‡A Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.‏ ‎‡9 1‏
919 ‎‡a survivalandmortalityinolderadultslivingathighaltitudeinboliviaapreliminaryreport‏ ‎‡A Survival and mortality in older adults living at high altitude in Bolivia: a preliminary report‏ ‎‡9 1‏
919 ‎‡a surgeryandriskofsporadiccreutzfeldtjakobdiseaseindenmarkandswedenregistrybasedcasecontrolstudies‏ ‎‡A Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies.‏ ‎‡9 1‏
919 ‎‡a suicideideationamongoncologicpatientsinaspanishward‏ ‎‡A Suicide ideation among oncologic patients in a Spanish ward.‏ ‎‡9 1‏
919 ‎‡a spinalcordinjuryduetotumourormetastasisinaragonnortheasternspain19912008incidencetimetrendsandneurologicalfunction‏ ‎‡A Spinal Cord Injury due to Tumour or Metastasis in Aragón, Northeastern Spain (1991-2008): Incidence, Time Trends, and Neurological Function.‏ ‎‡9 1‏
919 ‎‡a sonicationofabdominaldrainsclinicalimplicationsofquantitativeculturesforthediagnosisofsurgicalsiteinfection‏ ‎‡A Sonication of Abdominal Drains: Clinical Implications of Quantitative Cultures for the Diagnosis of Surgical Site Infection‏ ‎‡9 1‏
919 ‎‡a sleepdisorderedbreathingishighlyprevalentinpatientswithlungcancerresultsofthesleepapneainlungcancerstudy‏ ‎‡A Sleep Disordered Breathing Is Highly Prevalent in Patients with Lung Cancer: Results of the Sleep Apnea in Lung Cancer Study‏ ‎‡9 1‏
919 ‎‡a prevalenceofproteinenergywastingsyndromeanditsassociationwithmortalityinhaemodialysispatientsinacentreinspain‏ ‎‡A Prevalence of protein-energy wasting syndrome and its association with mortality in haemodialysis patients in a centre in Spain‏ ‎‡9 1‏
919 ‎‡a prevalenceofdisabilityinacomposite75yearoldpopulationinspainascreeningsurveybasedontheinternationalclassificationoffunctioning‏ ‎‡A Prevalence of disability in a composite ≥75 year-old population in Spain: a screening survey based on the International Classification of Functioning‏ ‎‡9 1‏
919 ‎‡a prevalenceofdementiaandmajordementiasubtypesinspanishpopulationsareanalysisofdementiaprevalencesurveys1990‏ ‎‡A Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008.‏ ‎‡9 1‏
919 ‎‡a prevalenceandeuropeancomparisonofdementiaina75yearoldcompositepopulationinspain‏ ‎‡A Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain‏ ‎‡9 1‏
919 ‎‡a pharmacogeneticsofmethylphenidateinchildhoodattentiondeficithyperactivitydisorderlongtermeffects‏ ‎‡A Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects.‏ ‎‡9 1‏
919 ‎‡a parathormonelevelsareindependentlyassociatedwiththepresenceofleftventricularhypertrophyinpatientswithcoronaryarterydisease‏ ‎‡A Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.‏ ‎‡9 1‏
919 ‎‡a outcomeofmildcognitiveimpairmentcomparingearlymemoryprofiles‏ ‎‡A Outcome of mild cognitive impairment comparing early memory profiles.‏ ‎‡9 1‏
919 ‎‡a nontuberculousmycobacteriamultispeciesbiofilmsincysticfibrosisdevelopmentofaninvitromycobacteriumabscessusandpseudomonasaeruginosadualspeciesbiofilmmodel‏ ‎‡A Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model‏ ‎‡9 1‏
919 ‎‡a nterminalprobrainnatriureticpeptideisassociatedwithafuturediagnosisofcancerinpatientswithcoronaryarterydisease‏ ‎‡A N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease‏ ‎‡9 1‏
919 ‎‡a modifiableriskfactorsforincreasedarterialstiffnessinoutpatientnephrology‏ ‎‡A Modifiable risk factors for increased arterial stiffness in outpatient nephrology‏ ‎‡9 1‏
919 ‎‡a lowintracellularwateroverhydrationandmortalityinhemodialysispatients‏ ‎‡A Low Intracellular Water, Overhydration, and Mortality in Hemodialysis Patients‏ ‎‡9 1‏
919 ‎‡a lipidbiomarkersaspredictorsofdiastolicdysfunctionindiabeteswithpoorglycemiccontrol‏ ‎‡A Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control‏ ‎‡9 1‏
919 ‎‡a influenceof3dimensionallungepithelialcellsandinterspeciesinteractionsonantibioticefficacyagainstmycobacteriumabscessusandpseudomonasaeruginosa‏ ‎‡A Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa‏ ‎‡9 1‏
919 ‎‡a incidenceoftraumaticspinalcordinjuryinaragonspain1972‏ ‎‡A Incidence of Traumatic Spinal Cord Injury in Aragón, Spain (1972–2008)‏ ‎‡9 1‏
919 ‎‡a incidenceofnontraumaticspinalcordinjuryaspanishcohortstudy1972‏ ‎‡A Incidence of nontraumatic spinal cord injury: a Spanish cohort study (1972-2008)‏ ‎‡9 1‏
919 ‎‡a impulsecontroldisorderinpatientswithparkinsonsdiseaseunderdopamineagonisttherapyamulticentrestudy‏ ‎‡A Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study‏ ‎‡9 1‏
919 ‎‡a importantabnormalitiesofbonemineralmetabolismarepresentinpatientswithcoronaryarterydiseasewithamilddecreaseoftheestimatedglomerularfiltrationrate‏ ‎‡A Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.‏ ‎‡9 1‏
919 ‎‡a impactofplasmaprobtypenatriureticpeptideaminoterminalandgalectin3levelsonthepredictivecapacityofthelipidclinicalriskscaleinstablecoronarydisease‏ ‎‡A [Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]‏ ‎‡9 1‏
919 ‎‡a impactofchiropracticmanipulationonboneandskeletalmuscleofovariectomizedrats‏ ‎‡A Impact of Chiropractic Manipulation on Bone and Skeletal Muscle of Ovariectomized Rats.‏ ‎‡9 1‏
919 ‎‡a genderalbuminuriaandchronickidneydiseaseprogressionintreateddiabetickidneydisease‏ ‎‡A Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease‏ ‎‡9 1‏
919 ‎‡a functionalptgs2polymorphismbasedmodelsasnovelpredictivemarkersinmetastaticrenalcellcarcinomapatientsreceiving1linesunitinib‏ ‎‡A Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib‏ ‎‡9 1‏
919 ‎‡a eosinophilsandchronicrespiratorydiseasesinhospitalizedcovid19patients‏ ‎‡A Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients‏ ‎‡9 1‏
919 ‎‡a effectofantibioticsandantibiofilmagentsintheultrastructureanddevelopmentofbiofilmsdevelopedbynonpigmentedrapidlygrowingmycobacteria‏ ‎‡A Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria.‏ ‎‡9 1‏
919 ‎‡a doopinionarticlesattractmoresocialattentionthanoriginalresearchrelativetotheircitationcounts‏ ‎‡A Do opinion articles attract more social attention than original research, relative to their citation counts?‏ ‎‡9 1‏
919 ‎‡a differentialprofileininflammatoryandmineralmetabolismbiomarkersinpatientswithischemicheartdiseasewithoutclassicalcoronaryriskfactors‏ ‎‡A Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.‏ ‎‡9 1‏
919 ‎‡a randomizeddoublemaskedstudytoevaluatetheeffectofomega3fattyacidssupplementationinmeibomianglanddysfunction‏ ‎‡A A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction‏ ‎‡9 1‏
919 ‎‡a anxietyanddepressionpredictmusculoskeletaldisordersinhealthcareworkers‏ ‎‡A Anxiety and depression predict musculoskeletal disorders in health care workers.‏ ‎‡9 1‏
919 ‎‡a arearticlessocialmediamentionsassociatedtocitationcountsananalysisinhighlyinfluentialmedicaljournals‏ ‎‡A Are article's social media mentions associated to citation counts? An analysis in highly influential medical journals.‏ ‎‡9 1‏
919 ‎‡a asthmadiagnosisusingintegratedanalysisofeosinophilmicrornas‏ ‎‡A Asthma diagnosis using integrated analysis of eosinophil microRNAs‏ ‎‡9 1‏
919 ‎‡a attentiondeficithyperactivitydisordergeneticassociationstudyinacohortofspanishchildren‏ ‎‡A Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish children‏ ‎‡9 1‏
919 ‎‡a behavioralevolutionofprogressivesemanticaphasiaincomparisonwithnonfluentaphasia‏ ‎‡A Behavioral Evolution of Progressive Semantic Aphasia in Comparison with Nonfluent Aphasia‏ ‎‡9 1‏
919 ‎‡a benefitsofomega3fattyaciddietarysupplementationonhealthrelatedqualityoflifeinpatientswithmeibomianglanddysfunction‏ ‎‡A Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction.‏ ‎‡9 1‏
919 ‎‡a biochemicalmarkersofboneturnoverandclinicaloutcomeinpatientswithrenalcellandbladdercarcinomawithbonemetastasesfollowingtreatmentwithzoledronicacidthetugamostudy‏ ‎‡A Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.‏ ‎‡9 1‏
919 ‎‡a boneturnovermarkersaspredictiveindicatorsofoutcomeinpatientswithbreastcancerandbonemetastasestreatedwithbisphosphonatesresultsfroma2yearmulticentreobservationalstudyzomarstudy‏ ‎‡A Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study)‏ ‎‡9 1‏
919 ‎‡a circulatingcxcl16indiabetickidneydisease‏ ‎‡A Circulating CXCL16 in Diabetic Kidney Disease.‏ ‎‡9 1‏
919 ‎‡a diagnosticvalueofthestandalonesyntheticimageindigitalbreasttomosynthesisexaminations‏ ‎‡A Diagnostic value of the stand-alone synthetic image in digital breast tomosynthesis examinations.‏ ‎‡9 1‏
919 ‎‡a designandrationaleofamulticentrerandomiseddoubleblindplacebocontrolledclinicaltrialtoevaluatetheeffectofvitamin500onventricularremodellinginpatientswithanteriormyocardialinfarctionthevitamin500inacutemyocardialinfa‏ ‎‡A Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infa‏ ‎‡9 1‏
919 ‎‡a costeffectivenessofdifferentscreeningstrategiessingleordualforthediagnosisoftuberculosisinfectioninhealthcareworkers‏ ‎‡A Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.‏ ‎‡9 1‏
943 ‎‡a 200x‏ ‎‡A 2008‏ ‎‡9 3‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BNE|XX4692098
996 ‎‡2 BNE|XX1232116
996 ‎‡2 ICCU|CUBV063229
996 ‎‡2 BNE|XX6289457
996 ‎‡2 BNC|981058611891506706
996 ‎‡2 BNF|13496671
996 ‎‡2 PTBNP|164123
996 ‎‡2 BIBSYS|1669188158000
996 ‎‡2 BNE|XX5441811
996 ‎‡2 ISNI|000000010941585X
996 ‎‡2 ISNI|0000000107807569
996 ‎‡2 NTA|074994727
996 ‎‡2 SUDOC|194277143
996 ‎‡2 BNE|XX5200313
996 ‎‡2 BNE|XX903842
996 ‎‡2 BNC|981058609312406706
996 ‎‡2 LC|no2016075280
996 ‎‡2 BNE|XX1110576
996 ‎‡2 DNB|143065947
996 ‎‡2 BNC|981058517855206706
996 ‎‡2 BNCHL|10000000000000000109748
996 ‎‡2 BNE|XX5089516
996 ‎‡2 ISNI|0000000060457089
996 ‎‡2 BNF|14197642
996 ‎‡2 SUDOC|077811313
996 ‎‡2 LC|ns2021000133
996 ‎‡2 BNC|981058517544906706
996 ‎‡2 ISNI|0000000059983102
996 ‎‡2 BNE|XX5451759
996 ‎‡2 NUKAT|n 2019221797
996 ‎‡2 DNB|171440595
996 ‎‡2 ARBABN|000070718
996 ‎‡2 BNE|XX1103473
996 ‎‡2 BNE|XX5586329
996 ‎‡2 BNE|XX1033411
996 ‎‡2 ICCU|CUBV063233
996 ‎‡2 BNC|981059252092606706
996 ‎‡2 ISNI|0000000059293187
996 ‎‡2 BNC|981058517061706706
996 ‎‡2 LC|nr2001038921
996 ‎‡2 BNE|XX1310325
996 ‎‡2 BNE|XX5886542
996 ‎‡2 BNE|XX852753
996 ‎‡2 SUDOC|260338109
996 ‎‡2 BNE|XX836376
996 ‎‡2 SUDOC|109395689
996 ‎‡2 BNE|XX1577811
996 ‎‡2 BIBSYS|7047404
996 ‎‡2 DNB|1239608950
996 ‎‡2 BNE|XX1780945
996 ‎‡2 RERO|A013285972
996 ‎‡2 BNC|981058530448206706
996 ‎‡2 NKC|jo2014820025
996 ‎‡2 BNE|XX5106881
996 ‎‡2 NUKAT|n 2008153051
996 ‎‡2 BNE|XX5560827
996 ‎‡2 BNE|XX5497364
996 ‎‡2 LC|no2008117164
996 ‎‡2 BNE|XX1104253
996 ‎‡2 BNE|XX1134634
996 ‎‡2 BNF|18046398
996 ‎‡2 JPG|500249953
996 ‎‡2 ISNI|0000000079916302
996 ‎‡2 ISNI|0000000060156040
996 ‎‡2 DNB|1292522151
996 ‎‡2 LC|n 83139580
996 ‎‡2 BNE|XX1553199
996 ‎‡2 SUDOC|230785875
996 ‎‡2 CAOONL|ncf11710825
996 ‎‡2 LC|no2003057878
996 ‎‡2 BNE|XX1196053
996 ‎‡2 BNCHL|10000000000000000828392
996 ‎‡2 LC|ns2021002544
996 ‎‡2 LC|n 2023180130
996 ‎‡2 BIBSYS|12065989
996 ‎‡2 PLWABN|9810662894405606
996 ‎‡2 LC|n 95102823
996 ‎‡2 ISNI|0000000059329856
996 ‎‡2 BNE|XX5033217
996 ‎‡2 BNE|XX894050
996 ‎‡2 ISNI|0000000080571858
996 ‎‡2 BNE|XX1201055
996 ‎‡2 BNE|XX1797866
996 ‎‡2 RERO|A009622328
996 ‎‡2 LC|n 88258410
996 ‎‡2 LC|no2012161546
996 ‎‡2 BNE|XX1798606
996 ‎‡2 RERO|A021508181
996 ‎‡2 BNE|XX1746731
996 ‎‡2 NKC|hka2009498661
996 ‎‡2 BNE|XX5746426
996 ‎‡2 NTA|115195327
996 ‎‡2 BNC|981058615708406706
996 ‎‡2 BNE|XX1073989
996 ‎‡2 DNB|1013803248
996 ‎‡2 LC|no2008045933
996 ‎‡2 BNE|XX1267977
996 ‎‡2 ISNI|0000000059806675
996 ‎‡2 ISNI|0000000509043565
996 ‎‡2 BNC|981058517446606706
996 ‎‡2 ISNI|0000000029005092
996 ‎‡2 J9U|987007362295705171
996 ‎‡2 DNB|1142259749
996 ‎‡2 ISNI|0000000114577757
996 ‎‡2 BNF|16681123
996 ‎‡2 RERO|A013112946
996 ‎‡2 LC|no2020125105
996 ‎‡2 SUDOC|136394787
996 ‎‡2 SUDOC|05863973X
996 ‎‡2 BNF|13531330
996 ‎‡2 BNC|981058508580506706
996 ‎‡2 BNC|981058515757706706
996 ‎‡2 LC|nr 93049682
996 ‎‡2 BNE|XX852541
996 ‎‡2 BNCHL|10000000000000000040666
996 ‎‡2 BNE|XX1430658
996 ‎‡2 BNE|XX1087646
996 ‎‡2 ISNI|0000000063026065
996 ‎‡2 ISNI|0000000060520885
996 ‎‡2 DNB|142673323
996 ‎‡2 SUDOC|268693188
996 ‎‡2 LC|no2011124246
996 ‎‡2 BNE|XX1074733
996 ‎‡2 CAOONL|ncf10725729
996 ‎‡2 DNB|1056439696
996 ‎‡2 BNE|XX5611049
996 ‎‡2 DNB|1244198870
996 ‎‡2 SUDOC|121846431
996 ‎‡2 DNB|132865904
996 ‎‡2 LC|n 99048127
996 ‎‡2 BNC|981058613151206706
996 ‎‡2 BNE|XX1439284
996 ‎‡2 SUDOC|232444544
996 ‎‡2 BNF|13476790
996 ‎‡2 BNE|XX5455365
996 ‎‡2 NTA|421749555
996 ‎‡2 BNE|XX1150448
996 ‎‡2 ISNI|0000000059866264
996 ‎‡2 BNE|XX1182937
996 ‎‡2 ISNI|0000000118615781
996 ‎‡2 RERO|A003238654
996 ‎‡2 BNCHL|10000000000000000252695
996 ‎‡2 BNE|XX832872
996 ‎‡2 SUDOC|270573003
996 ‎‡2 DNB|1283249189
996 ‎‡2 BNC|981061006975806706
996 ‎‡2 BNC|981058518470006706
996 ‎‡2 ISNI|0000000060946851
996 ‎‡2 ISNI|0000000115970032
996 ‎‡2 ISNI|0000000359893168
996 ‎‡2 BNE|XX1168049
996 ‎‡2 LC|n 2023000731
996 ‎‡2 BNE|XX6470769
996 ‎‡2 BNE|XX1542868
996 ‎‡2 SUDOC|129396273
996 ‎‡2 BNF|13967702
996 ‎‡2 BNC|981058526406306706
996 ‎‡2 LC|no2012072385
996 ‎‡2 BNC|981058611354406706
996 ‎‡2 BNE|XX1112939
996 ‎‡2 ISNI|0000000430961945
996 ‎‡2 SUDOC|262820366
996 ‎‡2 ISNI|000000011784788X
996 ‎‡2 J9U|987009842070705171
996 ‎‡2 BNE|XX1216945
996 ‎‡2 SUDOC|111096367
996 ‎‡2 BNC|981058612796306706
996 ‎‡2 DNB|174162103
996 ‎‡2 RERO|A018119631
996 ‎‡2 BNE|XX1012090
996 ‎‡2 BNE|XX1201808
996 ‎‡2 ISNI|0000000033515044
996 ‎‡2 DNB|1130248690
996 ‎‡2 BNE|XX4581477
996 ‎‡2 NYNYRILM|363907
996 ‎‡2 LC|n 95067967
996 ‎‡2 RERO|A008772192
996 ‎‡2 SUDOC|123796660
996 ‎‡2 BNE|XX4838838
996 ‎‡2 LC|n 2021251406
996 ‎‡2 SUDOC|050471279
996 ‎‡2 ISNI|0000000061511569
996 ‎‡2 DNB|1129461106
996 ‎‡2 SUDOC|168071800
996 ‎‡2 BNE|XX5357834
996 ‎‡2 BNE|XX968481
996 ‎‡2 BNE|XX4667567
996 ‎‡2 BNE|XX1060003
996 ‎‡2 BNC|981058513972106706
996 ‎‡2 BNE|XX5891217
996 ‎‡2 BNE|XX1771651
996 ‎‡2 RERO|A014357701
996 ‎‡2 RERO|A003238427
996 ‎‡2 NTA|229998070
996 ‎‡2 BNC|981058521563806706
996 ‎‡2 BNE|XX5610673
996 ‎‡2 BNE|XX4582045
996 ‎‡2 BNE|XX1476855
996 ‎‡2 ISNI|0000000116963985
996 ‎‡2 BNCHL|10000000000000000809454
996 ‎‡2 DNB|1166808777
996 ‎‡2 DNB|1300467517
996 ‎‡2 PTBNP|1186625
996 ‎‡2 BNC|981060882965406706
996 ‎‡2 ISNI|0000000104650762
996 ‎‡2 LC|no2024132457
996 ‎‡2 BNE|XX941423
996 ‎‡2 BNE|XX4663943
996 ‎‡2 BNE|XX1060247
996 ‎‡2 BNC|981060409104906706
996 ‎‡2 DNB|1057502375
996 ‎‡2 BNE|XX5409273
996 ‎‡2 ISNI|0000000117374330
996 ‎‡2 BNE|XX4717785
996 ‎‡2 BNE|XX1319920
996 ‎‡2 BNE|XX4768764
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏